Lupus, vaccinations and COVID-19: What we know now
Alice Mason(King's College Hospital), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Himashi Anver(University Hospital Southampton NHS Foundation Trust), Christopher Holroyd(Southampton General Hospital), Saul N. Faust(University Hospital Southampton NHS Foundation Trust), May Lwin(University Hospital Southampton NHS Foundation Trust)
Cited by 29
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k